Selexis CHO Cells in Suspension-1

Scientific Leadership

Connected in a culture of collaboration, compassion, and personal fulfillment, Selexis employees contribute to solutions that transcend the boundaries of individual day-to-day duties.

Severine_Fagete-350x350-2018SEP14

 

Séverine Fagète

VP, Cell Line Development Services


 

Séverine joined Selexis in December 2015 to lead the Cell Line Development, the Bioprocess and the Analytics Departments. In her role, she ensures the continuous generation of high-performance stable cell lines, including recombinant protein characterization. Séverine also works on providing scale-down bioreactor data using Ambr® 15 to facilitate the transfer to CMOs.

Séverine earned her PhD in protein engineering from a private company, Novimmune, where she focused on the generation of broad-spectrum chemokine inhibitors by using directed mutagenesis, phage display isolation, functional characterization and epitope mapping. She subsequently held a postdoctoral position at the University of Geneva (CH, Prof. Hartley’s group) where she designed a novel phage display platform for accelerating bispecific antibody development.